Congratulations to Jean Bennett, Katherine A. High and Albert Maguire, on winning the 2026 Breakthrough Prize in Life Sciences for developing LUXTURNA - a Gene Therapy for inherited retinal disease that became the first-ever FDA-approved gene therapy for a genetic disease. Luxturna is a one-time Gene Therapy treatment for inherited retinal disease caused by mutations in both copies of the RPE65 gene. Luxturna works by delivering a healthy copy of the RPE65 gene into the patient’s retina via a subretinal injection to help restore vision and has already cured hundreds of young patients by saving their eyesight. Godspeed!
@Ben_M_McLeod I was scrolling down and suddenly this video came in my feed and I thought to myself, am I on LinkedIn? 😳 oh no, it’s X, now Ben is on X too, haha!!! Looking forward to see your followers boom here too my friend
@EmmaRincon Even if Maria Corina is not in the ballot they should write her name and vote for her. They will have so many null ballots that the elections will be annulated